This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Taddei, S. Articles by Salvetti, A. Search for Related Content PubMed PubMed Citation Articles by Taddei, S. Articles by Salvetti, A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure Hazardous Substances DB PROPRANOLOL HYDROCHLORIDE

(Hypertension. 1995;25:595-601.)
© 1995 American Heart Association, Inc.

Articles

Angiotensin II and Sympathetic Activity in Sodium-Restricted Essential Hypertension

Stefano Taddei; Agostino Virdis; Paola Mattei; Stefania Favilla; Antonio Salvetti

From I Clinica Medica, University of Pisa (Italy).

Abstract Angiotensin II (Ang II) potentiates sympathetic neurotransmission by presynaptic facilitation of norepinephrine release. We investigated whether endogenous Ang II modulates peripheral sympathetic activity in sodium-depleted essential hypertensive patients. We evaluated the effect of intrabrachial infusion of saralasin, an Ang II antagonist (5 µg/100 mL forearm tissue per minute), and benazeprilat, an angiotensin-converting enzyme inhibitor (2 µg/100 mL forearm tissue per minute), on forearm vasoconstriction (measured by strain-gauge venous plethysmography) induced by the application of lower body negative pressure (-10 mm Hg for 5 minutes). Both saralasin and benazeprilat (n=6 for each group) blunted the vasoconstrictor action of lower body negative pressure, suggesting that circulating Ang II modulates peripheral sympathetic activity. In addition, since ß-adrenoceptor stimulation can activate the production of vascular Ang II, the effect of saralasin and benazeprilat on lower body negative pressure application was evaluated in the presence of isoproterenol (0.09 µg/100 mL forearm tissue per minute) and propranolol (10 µg/100 mL forearm tissue per minute). In two other groups of hypertensive patients, isoproterenol infusion increased the release of Ang II in the forearm vasculature (arteriovenous values measured by radioimmunoassay). Furthermore, isoproterenol potentiated lower body negative pressure–induced vasoconstriction. This facilitating effect was abolished by either saralasin or benazeprilat (n=6 for each group). In contrast, in two further groups of patients (n=6 for each group), in the presence of the ß-blocker propranolol, saralasin and benazeprilat did not alter the vasoconstrictor action of the endogenous sympathetic stimulus. The present data suggest that in sodium-depleted essential hypertensive patients, endogenous Ang II, activated by the stimulation of ß-adrenergic receptors, can potentiate peripheral sympathetic neurotransmission.

Key Words: sympathetic nervous system • angiotensin II • saralasin • norepinephrine • sodium, dietary

This article has been cited by other articles:

				G. H. Goossens, J. W.E. Jocken, E. E. Blaak, P. M. Schiffers, W. H.M. Saris, and M. A. van Baak Endocrine Role of the Renin-Angiotensin System in Human Adipose Tissue and Muscle: Effect of {beta}-Adrenergic Stimulation Hypertension, March 1, 2007; 49(3): 542 - 547. [Abstract] [Full Text] [PDF]

				S. Nielsen, J. R. Halliwill, M. J. Joyner, and M. D. Jensen Vascular Response to Angiotensin II in Upper Body Obesity Hypertension, October 1, 2004; 44(4): 435 - 441. [Abstract] [Full Text] [PDF]

				F. J He and G. A MacGregor Review: Salt, blood pressure and the renin-angiotensin system Journal of Renin-Angiotensin-Aldosterone System, March 1, 2003; 4(1): 11 - 16. [Abstract] [PDF]

				F. J. He, N. D. Markandu, and G. A. MacGregor Importance of the Renin System for Determining Blood Pressure Fall With Acute Salt Restriction in Hypertensive and Normotensive Whites Hypertension, September 1, 2001; 38(3): 321 - 325. [Abstract] [Full Text] [PDF]

				A. Virdis, L. Ghiadoni, M. Marzilli, E. Orsini, S. Favilla, P. Duranti, S. Taddei, P. Marraccini, and A. Salvetti Adenosine causes the release of active renin and angiotensin II in the coronary circulation of patients with essential hypertension J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1677 - 1684. [Abstract] [Full Text] [PDF]

				D E Newby, N E R Goodfield, A D Flapan, N A Boon, K A A Fox, and D J Webb Regulation of peripheral vascular tone in patients with heart failure: contribution of angiotensin II Heart, August 1, 1998; 80(2): 134 - 140. [Abstract] [Full Text]

				J. R. Petrie, A. D. Morris, K. Minamisawa, T. E. Hilditch, H. L. Elliott, M. Small, and J. MC Connell Dietary Sodium Restriction Impairs Insulin Sensitivity in Noninsulin-Dependent Diabetes Mellitus J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1552 - 1557. [Abstract] [Full Text]

				D. E Newby, S. Masumori, N. R Johnston, N. A Boon, and D. J Webb Endogenous angiotensin II contributes to basal peripheral vascular tone in sodium deplete but not sodium replete man Cardiovasc Res, November 1, 1997; 36(2): 268 - 275. [Abstract] [Full Text] [PDF]